secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2021-12-08T23:59:59+00:00
Accession:  0000950157-21-001239
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermo Fisher completes $17.4B acquisition of clinical research firm PPD, Inc.
------------------------------------------------------------------------------

- Total consideration $17.4 billion; PPD common stock ceased trading on Nasdaq.
- Deal expected to contribute $1.50 to Thermo Fisher's adjusted EPS in 2022.
- Synergies of ~$125M by year three: $75M cost, $50M revenue-related.
- Thermo Fisher assumes ~$3.0B net debt of PPD, all retired at closing.
- PPD to join Laboratory Products and Services Segment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000095015721001239/0000950157-21-001239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000095015721001239/form8k.htm
  HTML page:      https://secwatch.observer/filing/0000950157-21-001239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer